Black Rock Inc. Arrowhead Pharmaceuticals, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARWR
# of Institutions
298Shares Held
91.8MCall Options Held
199KPut Options Held
453K-
Vanguard Group Inc Valley Forge, PA12.2MShares$233 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$212 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$115 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$93.4 Million1.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.57MShares$68.3 Million0.04% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.02B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...